Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.10 | N/A |
| PEG Ratio (TTM) | -0.95 | N/A |
| P/S Ratio (TTM) | 1.42 | N/A |
| P/B Ratio (TTM) | 0.77 | N/A |
| P/FCF Ratio (TTM) | 12.36 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.05 | N/A |
| Price to 5YR AVG FCF Ratio | 11.53 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.55% | N/A |
| ROE (TTM) | 2.79% | N/A |
| Net Profit Margin (TTM) | 5.24% | N/A |
| ROIC 5YR AVG | 6.81% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -67.65% | 74.43% | 75.31% |
| Revenue | -0.64% | -0.20% | 0.34% |
| Net Income | -69.21% | 73.82% | 75.16% |
| Cash Flow | 6.22% | 28.53% | 18.53% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.06 | N/A |
| Quick Ratio (TTM) | 0.56 | N/A |
| D/E Ratio (TTM) | 0.42 | N/A |
| Interest Coverage (TTM) | 4.34 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.98 | N/A |
| LTL to 5YR AVG FCF | 6.18 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.13% | N/A |